A Court Just Cleared the Way for the Most Rewritten Title X Competition in 50 Years. $257 Million, 90 Awards, and a January 2027 Deadline.

Most grant competitions do not get sued before anyone submits an application. The FY2027 Title X Family Planning Services competition did — and on September 19, 2026, a federal judge in the Middle District of Pennsylvania threw the case out.

The dismissal did not decide whether the new funding announcement is lawful. It decided that nobody had yet been hurt enough to ask. That distinction matters enormously for the roughly 4,000 clinics in the Title X network, because it means the competition proceeds on schedule, on the government's terms, with the legal question deferred until after awards are made.

PA-FPH-27-001 is now the operative document. It obligates approximately $257 million across up to 90 awards, each running as long as five years, with individual awards ranging from $200,000 to $22 million and no cost-share requirement. It was posted April 3, 2026 by the Office of Population Affairs within the Office of the Assistant Secretary for Health, and the Grants.gov listing shows a close of January 11, 2027 at 6:00 p.m. ET — a date worth confirming directly, since several practitioner advisories have circulated January 9, 2027 instead. January 9 is a Saturday; January 11 is the Monday after. Do not build a submission plan around the later of two reported dates without checking the live listing.

What follows is an analysis of what changed, why the litigation failed, and what an applicant should actually do about it.

The competition this replaces

Title X has run on five-year grant cycles since its creation in 1970. The cycle now ending was awarded under the 2021 regulations, which restored the requirement that grantees provide nondirective counseling on all pregnancy options, including abortion referral on request — reversing the 2019 rule that had prohibited it.

That cycle did not end quietly. In spring 2025, the program withheld grant payments to 144 Planned Parenthood sites across 20 states. Eight grantees — spanning Ohio, the New England regions, Utah, Virginia, the Carolinas, and Minnesota and the Dakotas — received the final installment of their five-year awards in April 2026, which the administration characterized publicly as the last Title X money Planned Parenthood would see.

The network shrank accordingly. Planned Parenthood's Title X footprint fell from 297 clinics across 34 states and DC to 247 clinics across 29 states by May 2026, with California, Texas, and Ohio absorbing the largest reductions. Separately, 57 Planned Parenthood clinics in 20 states have closed or consolidated since January 2025, under combined pressure from Title X withholding, the Medina v. Planned Parenthood South Atlantic decision of June 26, 2025, and the one-year Medicaid funding prohibition enacted July 4, 2025.

The practical consequence for FY2027: a meaningful share of the incumbent network is either gone, reduced, or facing eligibility questions. This is not a competition where incumbency is the dominant variable it usually is in health services grantmaking.

What PA-FPH-27-001 actually changes

Three categories of change matter, and they operate differently.

1. The definition of a Title X service expanded

The retained core is familiar: pregnancy testing, STI and HIV services, basic infertility services, preconception health counseling, and contraceptive services.

What is new is the surrounding scope. Per Feldesman LLP's analysis of the announcement, the FY2027 NOFO adds services addressing male sexual health — including low testosterone and erectile dysfunction — chronic disease management through nutrition and physical activity, sleep health, strategies to reduce pornography use, and environmental toxin exposure.

Read that list as a program-design instruction rather than a political statement, because that is how it will function in review. A Title X applicant in FY2027 is being asked to describe a clinic that does substantially more than family planning as the program has defined it for five decades. If your budget, staffing model, and referral network were built for the old scope, the narrative you submit will read as under-responsive against applicants who built to the new one.

2. The programmatic priorities shifted

The announcement elevates body literacy education, reproductive life-planning counseling, fertility-awareness based methods, and lifestyle and chronic disease management. KFF's read is that this represents a shift in programmatic priority "from contraceptive access and pregnancy prevention to fertility-awareness based methods and family formation."

Applicants are also directed to address administration-wide priorities, including eliminating diversity, equity, and inclusion practices and preventing the facilitation of illegal immigration — the same cross-cutting conditions that have appeared across federal awards this year and that are separately under challenge at USDA, as we covered in the Agroecology Commons suit over USDA grant terms.

3. The abortion provisions moved again

HHS has stated it will not require grantees, individuals, or institutions covered by the Weldon Amendment to counsel or refer for abortion, notwithstanding the program's current regulations. And facilities that perform abortion or refer for it face ineligibility.

Note the structure of that first clause. It is not a regulatory amendment. It is an announcement that a statutory conscience protection will be read to override the existing rule's counseling mandate for covered entities. That is a durable posture for the length of this five-year cycle regardless of what happens to the 2021 regulations later.

Why the lawsuit failed — and what that tells you

The National Family Planning & Reproductive Health Association and the Family Health Council of Central Pennsylvania — which serves more than 31,000 patients annually across 24 Pennsylvania counties — filed suit on June 18, 2026, represented by the ACLU. Their core claim was that the announcement prioritizes ideology over quality and qualifications, contrary to the statute's direction that HHS evaluate applicants on factors like the number of patients served, local need, and capacity to use funds effectively.

The government moved to dismiss on July 31, 2026. Judge Jennifer Wilson granted the motion on September 19, 2026, finding no real and immediate harm to the plaintiffs at this stage. Her reasoning included a line every grant professional should sit with: an ambiguous set of scoring criteria, applicable to all applicants alike, does not affect competition differently than a clear set would.

The dismissal was without prejudice. Plaintiffs can return.

The strategic lesson is procedural, not political, and it generalizes well beyond Title X. A pre-award challenge to evaluation criteria is very hard to win. Courts treat the injury as speculative until an applicant has actually applied and actually lost. The Title X plaintiffs are now in the position the doctrine pushes everyone toward: apply under criteria you believe are unlawful, preserve your objections, and litigate after the award decision — by which point the money is committed and the remedy is far narrower.

A separate action, Planned Parenthood Federation of America v. HHS, was filed in the District of Columbia on July 28, 2026. Its posture differs, and applicants should track it, but nothing about it changes the January deadline.

The arithmetic nobody is publishing

Run the numbers on the award structure, because they are unusually informative.

$257 million across up to 90 awards averages roughly $2.86 million per award per year — but the stated range runs from $200,000 to $22 million, a 110-fold spread. That range tells you the program intends to fund both single-state and multi-state grantees, and that a handful of large awards will consume a disproportionate share of the pool. If ten awards land near the ceiling, they alone absorb a substantial fraction of the total and the remaining eighty compete for what is left.

Two implications follow.

First, small and mid-size applicants should not anchor on the average. An organization proposing a $3 million annual budget because that is the arithmetic mean is proposing a number the program has not signaled it wants. Propose the service area you can actually cover, priced honestly.

Second, the absence of a cost-share requirement is a genuine opening. Title X has long been accessible to organizations without matching capacity, and that remains true. In a year when much of the incumbent network is contracting, a community health center, health department, or tribal organization that has never held a Title X grant faces a more open field than at any point in the program's recent history.

Eligibility is broad: public and private nonprofit entities, including government agencies, educational institutions, and tribal organizations.

What to do before January

1. Verify the deadline against the live Grants.gov listing today. Two dates are circulating. The listing was last updated July 9, 2026, and further modifications are possible on a NOFO this contested.

2. Read the full announcement, not a summary of it. Including this one. A competition whose service definition changed this much will be scored against language that no secondary source reproduces completely.

3. Map the expanded service scope against what you actually deliver. For each new area — male sexual health, nutrition and physical activity, sleep, environmental exposure, fertility-awareness methods — decide now whether you will deliver it directly, deliver it through a partner, or decline to address it. Each is a defensible choice. What is not defensible is leaving it unaddressed in the narrative.

4. Decide your posture on the priority conditions deliberately, at board level. Some organizations will conclude the conditions are incompatible with their mission and will not apply. That is a legitimate decision, and making it early is far better than making it in December. For those who do apply, the conditions are terms of the award, and accepting an award means accepting them — with the enforcement consequences that attach, which we examined in the agency-priorities termination clause analysis.

5. Assess the incumbency vacuum in your service area honestly. Pull the current Title X grantee list for your state. If the incumbent has withdrawn, closed sites, or faces an eligibility question, document the coverage gap with data — patient counts, county-level need, travel distance — and build your application around filling it. Demonstrated local need is a statutory evaluation factor, and it is the factor least affected by everything else that has changed.

6. Budget for a five-year award, not a one-year one. The project period runs up to five years. Staffing and infrastructure decisions made in this application persist through 2032.

7. Do not wait for the litigation to resolve. It will not resolve before January, and the dismissal makes clear that the courthouse door opens after the award decision, not before. An organization that skips the competition to await legal clarity forfeits the competition and gains nothing.

The larger pattern

Title X in FY2027 is a clean example of something now visible across the federal grants landscape: the substantive policy fight has moved out of rulemaking — where notice, comment, and judicial review apply with force — and into the funding announcement, where a court will tell you your objections are premature until the money is gone.

The OMB proposal to rewrite 2 CFR Part 200 would formalize parts of that shift, and it is currently frozen through December 11, 2026 by statute. But the Title X NOFO demonstrates that agencies do not need the rewrite to operate this way. The announcement is where the criteria live, the criteria are where the policy lives, and the review is where it gets applied.

For applicants, that means the grant narrative has quietly become the place where these questions get answered — one organization at a time, in writing, under deadline. The FY2027 Title X deadline is in January.

Sources: Grants.gov / Simpler.Grants.gov opportunity listing PA-FPH-27-001, Feldesman LLP analysis of FY2027 Title X compliance requirements, KFF update on Medicaid, Title X, and Planned Parenthood, ACLU press release on the NFPRHA complaint, Stateline coverage of the dismissal.